1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
The Green Rush may be upon us. Cannabis investment research firm ArcView estimates that legal North American marijuana sales hit more than $8 billion in 2017, up 22% from the year before. What’s more,...
While the foreseeable future for the broad market may not be clear, there’s one group that still moves independently of stocks as a whole — biotech stocks.
These stocks are still pushed...
As legalization expands, companies linked to marijuana are getting lots of attention. But nearly all are iffy penny stocks not worthy of your investment.
More Investing News »